A clinical trial of a cannabis extract to treat patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome (ACOS).

Trial Profile

A clinical trial of a cannabis extract to treat patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome (ACOS).

Planning
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2017

At a glance

  • Drugs CS TATI-1 (Primary)
  • Indications Respiratory tract disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Nov 2017 New trial record
    • 28 Nov 2017 According to a Cannabis Science media release, soon the company will initiate this trial for to treat patients with Asthma and COPD Overlap Syndrome (ACOS)).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top